KPC Pharmaceuticals,Inc. (SHA:600422)
China flag China · Delayed Price · Currency is CNY
12.15
-0.01 (-0.08%)
Mar 10, 2026, 3:00 PM CST

KPC Pharmaceuticals,Inc. Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
-2,2711,5001,6581,574
Upgrade
Trading Asset Securities
-471.28603.8319.4160.5
Upgrade
Cash & Short-Term Investments
2,7592,7422,1031,9781,735
Upgrade
Cash Growth
0.64%30.36%6.35%14.01%-4.68%
Upgrade
Accounts Receivable
-3,8553,2252,6252,011
Upgrade
Other Receivables
-123.73797.7595.1169.09
Upgrade
Receivables
-3,9794,0222,7202,180
Upgrade
Inventory
-1,5401,7721,6811,884
Upgrade
Other Current Assets
-294.82250.14388.21381.96
Upgrade
Total Current Assets
-8,5558,1486,7666,180
Upgrade
Property, Plant & Equipment
-1,2861,3071,2911,361
Upgrade
Long-Term Investments
-305.46319.61320.61278.24
Upgrade
Goodwill
-1,5031,50391.7391.73
Upgrade
Other Intangible Assets
-412.22441.97355.98408.88
Upgrade
Long-Term Deferred Tax Assets
-258.28269.12245.6233.83
Upgrade
Long-Term Deferred Charges
-237.84237199.07274.49
Upgrade
Other Long-Term Assets
-53.1269.83161.1764.98
Upgrade
Total Assets
-12,61112,2959,4328,893
Upgrade
Accounts Payable
-1,056936.78977.121,239
Upgrade
Accrued Expenses
-1,8311,5971,2621,117
Upgrade
Short-Term Debt
-658.04725.49912.76641.75
Upgrade
Current Portion of Long-Term Debt
-61.05199.50.2
Upgrade
Current Portion of Leases
-19.2822.4622.5736.07
Upgrade
Current Income Taxes Payable
-158.94149.7578.7693.28
Upgrade
Current Unearned Revenue
-83.32102.63186.3774.09
Upgrade
Other Current Liabilities
-1,624329.7350.01284.76
Upgrade
Total Current Liabilities
-5,4913,8653,8893,485
Upgrade
Long-Term Debt
-46.05107.566099.5
Upgrade
Long-Term Leases
-48.5944.2444.7750.47
Upgrade
Long-Term Unearned Revenue
-229.92224.09207.58245.34
Upgrade
Long-Term Deferred Tax Liabilities
-21.6524.2810.6415.42
Upgrade
Other Long-Term Liabilities
-28.0375.9777.5856.67
Upgrade
Total Liabilities
-5,8654,3414,2893,953
Upgrade
Common Stock
-756.98757.99758.26758.26
Upgrade
Additional Paid-In Capital
-520.622,3271,1611,169
Upgrade
Retained Earnings
-3,9813,4903,0712,894
Upgrade
Treasury Stock
---10.42-13.15-26.3
Upgrade
Comprehensive Income & Other
--5.29-1.626.3-11.5
Upgrade
Total Common Equity
5,3095,2546,5624,9834,783
Upgrade
Minority Interest
-1,4931,392159.5156.98
Upgrade
Shareholders' Equity
6,8566,7467,9545,1434,940
Upgrade
Total Liabilities & Equity
-12,61112,2959,4328,893
Upgrade
Total Debt
1,693833.02900.741,140828
Upgrade
Net Cash (Debt)
1,0661,9091,203838.19906.76
Upgrade
Net Cash Growth
-44.15%58.73%43.47%-7.56%-9.49%
Upgrade
Net Cash Per Share
1.402.531.581.121.20
Upgrade
Filing Date Shares Outstanding
756.98756.98757.11758.13758.26
Upgrade
Total Common Shares Outstanding
756.98756.98757.99758.26758.26
Upgrade
Working Capital
-3,0644,2832,8782,695
Upgrade
Book Value Per Share
7.016.948.666.576.31
Upgrade
Tangible Book Value
3,4323,3384,6174,5354,283
Upgrade
Tangible Book Value Per Share
4.534.416.095.985.65
Upgrade
Buildings
-1,3251,2621,1371,136
Upgrade
Machinery
-1,0581,011988.66980.07
Upgrade
Construction In Progress
-76.46100.5164.6543.51
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.